FDA Inspection 1173100 — Department Of Defense - Navy
The FDA completed an inspection of Department Of Defense - Navy on Jun 16, 2022 in Guantanamo Bay. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 16, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Guantanamo Bay (Cuba)